2013
DOI: 10.11622/smedj.2013037
|View full text |Cite
|
Sign up to set email alerts
|

Regular paracetamol in severe dengue: a lethal combination?

Abstract: An eight-month-old female infant with severe dengue disease, who was repeatedly given therapeutic paracetamol for severe dengue, developed fulminant liver failure with encephalopathy, gastrointestinal haemorrhage and severe coagulopathy. She responded to supportive measures and N-acetylcysteine infusion. This case highlights the potential danger of administering repeated therapeutic doses of paracetamol in childhood severe dengue disease with hepatitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 9 publications
0
13
0
Order By: Relevance
“…APAP is the most commonly used drug to treat dengue symptoms [ 6 ] and there are studies showing that dengue patients who use APAP are at increased risk of developing liver failure [ 14 ]. Many studies have evaluated the liver damage resulting from the association between DENV and APAP [ 6 , 15 , 36 , 37 ] but, despite evidence suggesting that this association may lead to severe hepatic insufficiency, no studies have yet been performed to evaluate cellular and molecular mechanisms involved in hepatocyte response to the association between DENV and APAP. Thus, this study evaluated the transcriptional changes in hepatocytes resulting from the association between DENV infection and APAP treatment and the possible effects of these changes on the molecular and cellular mechanisms that influence cellular homeostasis.…”
Section: Discussionmentioning
confidence: 99%
“…APAP is the most commonly used drug to treat dengue symptoms [ 6 ] and there are studies showing that dengue patients who use APAP are at increased risk of developing liver failure [ 14 ]. Many studies have evaluated the liver damage resulting from the association between DENV and APAP [ 6 , 15 , 36 , 37 ] but, despite evidence suggesting that this association may lead to severe hepatic insufficiency, no studies have yet been performed to evaluate cellular and molecular mechanisms involved in hepatocyte response to the association between DENV and APAP. Thus, this study evaluated the transcriptional changes in hepatocytes resulting from the association between DENV infection and APAP treatment and the possible effects of these changes on the molecular and cellular mechanisms that influence cellular homeostasis.…”
Section: Discussionmentioning
confidence: 99%
“…However, acetaminophen is available over-the-counter at no charge, extensively advertised in the lay media, and part of the therapeutic routine recommended by the Brazilian Ministry of Health 8 for self-treatment of dengue symptoms. Repeated acetaminophen use, even at therapeutic doses, may increase serum aminotransferase levels; inadvertent use of high doses may lead to severe liver injury and death [15][16][17] . Considering, the high frequency of hepatic impairment observed in this study, we advise that acetaminophen be used with caution in cases of DHF.…”
Section: Discussionmentioning
confidence: 99%
“…The effects of potentially hepatotoxic drugs taken during the early stage of the disease on liver dysfunction are still controversial. 22,23 Because this study was retrospective, we could not collect data on the intake of acetaminophen or other hepatotoxic drugs in our studied population. Only five adults and three children received antibiotics, and no differences in liver dysfunction were observed.…”
Section: Discussionmentioning
confidence: 99%